IP Library Granted Patent US 9,850,545
Granted Patent B2
US 9,850,545 · App. 14/314,985 · Granted Dec 26, 2017

Multi-primer assay for

Inventors: Olga Petrauskene (San Carlos, CA); Pius Brzoska (Woodside, CA); Somaya Bit (San Ramon, CA); Jen-Kuei Liu (Palo Alto, CA); Robert Tebbs (Austin, TX); Manohar Furtado (San Ramon, CA)
Assignee: Life Technologies Corporation
C12Q1/689C12Q2600/16
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,850,545
App. No.
14/314,985
Granted
Dec 26, 2017
Kind
B2
Abstract

Disclosed is a multi-primer amplification assay, method and kits for detecting Mycoplasma species and closely related species utilizing a plurality of oligonucleotide primers in contact with a sample in a single vessel and detecting the amplification product, wherein the presence of an amplification product indicates Mycoplasma in the sample.

Claims (31)

1. A multi-primer assay for detecting Mycoplasma in a sample, comprising:

a.) contacting the sample with the plurality of oligonucleotide primers selected from the group consisting of SEQ ID NOs:1-144 in a single vessel;

b.) performing a multi-primer amplification reaction in the vessel in the presence of a nucleic acid dye or a dye probe, wherein each of the plurality of oligonucleotide primers is present for participation in amplifying a target nucleic acid in the sample to produce an amplification product comprising the nucleic acid dye or the dye probe; and

c.) detecting a signal from the nucleic acid dye or the dye probe of the amplification product, wherein the presence of an amplification product indicates Mycoplasma in the sample;

wherein the assay is capable of detecting more than 90 Mycoplasma species or related microorganisms Acholeplama laidlwaii and Spiroplasma citri.

2. The assay according to claim 1 , wherein at least one of the plurality of oligonucleotide primers comprises a modified nucleobase at the third or fourth nucleobase from the 3′ end of the primer.

3. The assay of claim 1 wherein the plurality of primers comprises at least 15 forward primers and at least 16 reverse primers.

4. The assay according to claim 1 , wherein the plurality of oligonucleotide primers comprises at least twenty oligonucleotide primers.

5. The assay according to claim 1 , wherein the sample comprises either a cell culture, a tissue culture, a food sample, an environmental sample, an agricultural sample, a biopharmaceutical sample, a pharmaceutical sample, or water.

6. The assay according to claim 1 , wherein the contacting comprises hybridizing one or more of the oligonucleotide primers to a target nucleic acid in the sample.

7. The assay according to claim 6 , wherein the target nucleic acid is extracted from the sample prior to hybridizing with the one or more oligonucleotide primers.

8. The assay according to claim 1 , wherein the detecting comprises a detector selected from the group consisting of a nucleic acid dye, a reporter probe, or a reporter probe and a nucleic acid dye.

9. The assay according to claim 1 , wherein the assay comprises a discriminatory positive control (DPC) nucleic acid.

10. The assay according to claim 9 , wherein the DPC nucleic acid is added to the sample prior to extraction of the target nucleic acid of the sample.

11. The assay according to claim 10 , wherein the DPC nucleic acid is extracted simultaneously with the target nucleic acid of the sample.

12. The assay according to claim 11 , wherein the DPC nucleic acid is amplified in the multi-primer amplification reaction and the DPC amplification product is detected.

13. The assay according to claim 12 , wherein the detecting comprises a melting temperature for the discriminatory positive control distinguishable from a melting temperature for the Mycoplasma.

14. The assay according to claim 13 , wherein detection of the DPC amplification product and no detection of the Mycoplasma amplification product is a confirmed negative assay for Mycoplasma ; wherein detection of the DPC amplification product and detection of the Mycoplasma amplification product is a confirmed positive assay for Mycoplasma.

15. A method for detecting Mycoplasma comprising:

a.) extracting nucleic acid from a sample to be tested for Mycoplasma;

b.) combining in a single vessel a plurality of oligonucleotide primers and the nucleic acid from the sample;

c.) contacting the nucleic acid from the sample with the plurality of oligonucleotide primers in the vessel, said oligonucleotide primers selected from the group consisting of SEQ ID NOS:1-144;

d.) performing a multi-primer amplification reaction in the vessel, wherein each of the plurality of oligonucleotide primers is present for participation in amplifying the sample to produce an amplification product; and

e.) detecting the amplification product, wherein the presence of the amplification product indicates Mycoplasma in the sample;

wherein the assay can detect more than 90 Mycoplasma species or related microorganisms Acholeplama laidlwaii and Spiroplasma citri.

16. The method for detecting Mycoplasma of claim 15 comprising:

a.) optionally, combining a discriminating positive control (DPC) nucleic acid with the sample to be tested for Mycoplasma ;

b.) extracting nucleic acid from the combined sample and DPC.

17. The method for detecting Mycoplasma of claim 15 , wherein a DPC nucleic acid is added to the vessel.

18. The method for detecting Mycoplasma of claim 17 , wherein the DPC nucleic acid is amplified in the multi-primer amplification reaction and the DPC amplification product is detected.

19. The method for detecting Mycoplasma of claim 18 , wherein the detecting comprises a melting temperature for the discriminatory positive control distinguishable from a melting temperature for the Mycoplasma.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 5, 2016
From: PETRAUSKENE, OLGA; BRZOSKA, PIUS M.; BIT, SOMAYA; LIU, JEN-KUEI A; TEBBS, ROBERT STERLING; FURTADO, MANOHAR R
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 037679/0664 →
Continuity (4)
Continuation 12916420 · Oct 29, 2010
Provisional Application 61262492 · Nov 18, 2009
Provisional Application 61256413 · Oct 30, 2009
Related Publication 20140378330A1 · Dec 25, 2014